ROCKWELL MEDICAL, INC. — Form 8-K
Filed August 13, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
Rockwell Medical (market cap ~$28.7M) filed an 8-K on 2026-08-13 disclosing Q2 2026 presentation materials under Regulation FD. The filing includes a presentation document with 16 slides but contains no specific financial data, dollar amounts, counterparty information, or business developments disclosed in the text provided. Actual content details are embedded in graphic files not readable in this format.
Why this rating
Routine disclosure of presentation slides. No material business event, financing, partnership, or financial metric disclosed in accessible text. Standard periodic investor communication.
Extracted items
- 7.01 Reg FD disclosure
- 9.01 exhibits
See more from August 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.